Manufacturer: Eminence Labs
Substance: Eminence Labs
Package: 250mg/amp. (10 amps)



General information about Cytopilin 250 in Italy

Cytopilin 250 (Testosterone Cypionate) is a long-acting, single-ester form of testosterone. Due to the length of its ester (8 carbon atoms), it is largely stored in adipose tissue after intramuscular injection and then released slowly but very steadily over a period of time. A peak is noted 24-48 hours after injection and then a slow decline, reaching a plateau after 12 days and remaining there for more than 3 weeks. A long-acting testosterone ester may be the best for all your bulking needs, but it is not an easy product to use. Nolvadex and Proviron will be very useful in these cases and post-cycle. HCG and Clomid or Nolvadex will also be needed to help restore natural testosterone. The frequency of side effects is probably higher with this type of product.

Features Cytopilin 250 in Italy

The aromatization rate of this type of testosterone is quite large, so water retention and fat gain are a given and gynecomastia can be a problem. If problems occur, it is best to start with Nolvadex 20 mg per day and continue until the problems go away. I wouldn't want to stay on it for a full cycle as it can reduce profits.

Interaction with other drugs in Italy

Testosterone is one of the few compounds where Proviron may be preferred Arimidex. Proviron will not only reduce estrogen and can be used over a long period of time, in a testosterone cycle, it will also be the high affinity binding of sex hormone binding proteins in the blood and allow for a higher level of free testosterone. in the blood. .body, thus enhancing gains.Typical side effects may include nausea, acne, excitement or increased aggression, tremors, high blood pressure, increased libido. You can find more information about Test Cyp at the information on the Testosterone Cypionate Information Site.

Usage: 500-1000 mg per week.


There are no reviews yet.

Be the first to review “Cypoprime”

Your email address will not be published. Required fields are marked *